Erick Mwamba Miaka

Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial

Victor Kande Betu Kumeso, Wilfried Mutombo Kalonji, Sandra Rembry et al. · The Lancet Infectious Diseases · 2022 · 105 citations · Full text

Impact of tiny targets on Glossina fuscipes quanzensis, the primary vector of human African trypanosomiasis in the Democratic Republic of the Congo

Iñaki Tirados, Andrew Hope, Richard Selby et al. · PLoS neglected tropical diseases · 2020 · 56 citations · Full text

Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo

R. E. Crump, Ching-I Huang, Edward Knock et al. · PLoS Computational Biology · 2021 · 38 citations · Full text

Parasitic Disease, Malaria, Disease Mapping +26

Village-scale persistence and elimination of gambiense human African trypanosomiasis

Christopher N. Davis, Kat S. Rock, Erick Mwamba Miaka et al. · PLoS neglected tropical diseases · 2019 · 37 citations · Full text

Biology, Infectious Disease Modelling, Epidemiology +15

Screening Strategies for a Sustainable Endpoint for Gambiense Sleeping Sickness

Soledad Castaño, Maryam Aliee, Erick Mwamba Miaka et al. · The Journal of Infectious Diseases · 2019 · 37 citations · Full text